These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1547193)

  • 1. Low density lipoproteins inhibit endotoxin activation of monocytes.
    Weinstock C; Ullrich H; Hohe R; Berg A; Baumstark MW; Frey I; Northoff H; Flegel WA
    Arterioscler Thromb; 1992 Mar; 12(3):341-7. PubMed ID: 1547193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.
    Flegel WA; Baumstark MW; Weinstock C; Berg A; Northoff H
    Infect Immun; 1993 Dec; 61(12):5140-6. PubMed ID: 8225591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies.
    Richter WO; Jacob BG; Ritter MM; Sühler K; Vierneisel K; Schwandt P
    Metabolism; 1993 Jul; 42(7):888-94. PubMed ID: 8345799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
    Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
    Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levels.
    Ritter MM; Sühler K; Richter W; Schwandt P
    Clin Chim Acta; 1990 Dec; 195(1-2):9-15. PubMed ID: 2151209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients.
    Dargent A; Pais de Barros JP; Saheb S; Bittar R; Le Goff W; Carrié A; Gautier T; Fournel I; Rerole AL; Choubley H; Masson D; Lagrost L; Quenot JP
    J Lipid Res; 2020 Dec; 61(12):1776-1783. PubMed ID: 33037132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lipoproteins in the inactivation of endotoxin by serum.
    Northoff H; Flegel WA; Yurttas R; Weinstock C
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):202-3. PubMed ID: 1422080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the long-term efficacy and selectivity of immunoadsorption columns for low density lipoprotein apheresis.
    Jovin IS; Taborski U; Müller-Berghaus G
    ASAIO J; 2000; 46(3):298-300. PubMed ID: 10826740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo.
    Kostner K; Banyai S; Jansen M; Khoschsorur G; Hörl WH; Maurer G; Winklhofer-Roob B; Derfler K
    Clin Chim Acta; 1999 Oct; 288(1-2):21-30. PubMed ID: 10529454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of LDL apheresis on restenosis after angioplasty.
    Kanemitsu S; Tekekoshi N; Murakami E
    Chem Phys Lipids; 1994 Jan; 67-68():339-43. PubMed ID: 8187232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
    Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
    Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosorptive apheresis of LDL.
    Borberg H; Gaczkowski A; Oette K; Stoffel W
    Prog Clin Biol Res; 1990; 337():163-7. PubMed ID: 2191310
    [No Abstract]   [Full Text] [Related]  

  • 16. Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects.
    Kobayashi J; Katsube S; Shimoda M; Furuhashi K; Kitano S; Masuda M; Maruyama T; Shinomiya M
    Clin Chim Acta; 2002 Jul; 321(1-2):107-12. PubMed ID: 12031599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
    Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
    Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for familial defective apolipoprotein B-100 with improved U937 monocyte proliferation assay.
    Van den Broek AJ; Hollaar L; Schaefer HI; Van der Laarse A; Schuster H; Defesche JC; Kastelein JJ; Van 't Hooft FM
    Clin Chem; 1994 Mar; 40(3):395-9. PubMed ID: 8131274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.